102 related articles for article (PubMed ID: 17198880)
1. Quantitative assessment of human T lymphocytes in RAG2(-/-)gammac(-/-) mice: the impact of ex vivo manipulation on in vivo functionality.
van Rijn RS; Simonetti ER; Hagenbeek A; Bonyhadi M; Storm G; Martens AC; Ebeling SB
Exp Hematol; 2007 Jan; 35(1):117-27. PubMed ID: 17198880
[TBL] [Abstract][Full Text] [Related]
2. Human regulatory T cells control xenogeneic graft-versus-host disease induced by autologous T cells in RAG2-/-gammac-/- immunodeficient mice.
Mutis T; van Rijn RS; Simonetti ER; Aarts-Riemens T; Emmelot ME; van Bloois L; Martens A; Verdonck LF; Ebeling SB
Clin Cancer Res; 2006 Sep; 12(18):5520-5. PubMed ID: 17000688
[TBL] [Abstract][Full Text] [Related]
3. Reconstitution of human lymphocytes following ex vivo expansion of human umbilical cord blood CD34+ cells and transplantation in Rag2-/- gamma c-/- mice model.
Choi BK; Joo SY; Moon C; Park KS; Kim SH; Park JB; Jung GO; Choi GS; Kwon CH; Chun JM; Joh JW; Lee SK; Kim SJ
Transplant Proc; 2008 Oct; 40(8):2655-60. PubMed ID: 18929829
[TBL] [Abstract][Full Text] [Related]
4. Enhanced engraftment of human cells in RAG2/gammac double-knockout mice after treatment with CL2MDP liposomes.
Rozemuller H; Knaän-Shanzer S; Hagenbeek A; van Bloois L; Storm G; Martens AC
Exp Hematol; 2004 Nov; 32(11):1118-25. PubMed ID: 15539091
[TBL] [Abstract][Full Text] [Related]
5. Adoptively transferred tumor-specific T cells stimulated ex vivo using herpes simplex virus amplicons encoding 4-1BBL persist in the host and show antitumor activity in vivo.
Yi KH; Nechushtan H; Bowers WJ; Walker GR; Zhang Y; Pham DG; Podack ER; Federoff HJ; Tolba KA; Rosenblatt JD
Cancer Res; 2007 Oct; 67(20):10027-37. PubMed ID: 17942937
[TBL] [Abstract][Full Text] [Related]
6. Development of functional human immune system with the transplantations of human fetal liver/thymus tissues and expanded hematopoietic stem cells in RAG2-/-gamma(c)-/- MICE.
Joo SY; Choi BK; Kang MJ; Jung DY; Park KS; Park JB; Choi GS; Joh J; Kwon CH; Jung GO; Lee SK; Kim SJ
Transplant Proc; 2009 Jun; 41(5):1885-90. PubMed ID: 19545750
[TBL] [Abstract][Full Text] [Related]
7. High metastatic efficiency of human sarcoma cells in Rag2/gammac double knockout mice provides a powerful test system for antimetastatic targeted therapy.
Nanni P; Nicoletti G; Landuzzi L; Croci S; Murgo A; Palladini A; Antognoli A; Ianzano ML; Stivani V; Grosso V; Maira SM; García-Echeverría C; Scotlandi K; De Giovanni C; Lollini PL
Eur J Cancer; 2010 Feb; 46(3):659-68. PubMed ID: 20031388
[TBL] [Abstract][Full Text] [Related]
8. Tumor antigen-specific T-cell expansion is greatly facilitated by in vivo priming.
Dang Y; Knutson KL; Goodell V; dela Rosa C; Salazar LG; Higgins D; Childs J; Disis ML
Clin Cancer Res; 2007 Mar; 13(6):1883-91. PubMed ID: 17363545
[TBL] [Abstract][Full Text] [Related]
9. Umbilical cord blood xenografts in immunodeficient mice reveal that T cells enhance hematopoietic engraftment beyond overcoming immune barriers by stimulating stem cell differentiation.
Hexner EO; Danet-Desnoyers GA; Zhang Y; Frank DM; Riley JL; Levine BL; Porter DL; June CH; Emerson SG
Biol Blood Marrow Transplant; 2007 Oct; 13(10):1135-44. PubMed ID: 17889349
[TBL] [Abstract][Full Text] [Related]
10. 4-1BB costimulation of effector T cells for adoptive immunotherapy of cancer: involvement of Bcl gene family members.
Kroon HM; Li Q; Teitz-Tennenbaum S; Whitfield JR; Noone AM; Chang AE
J Immunother; 2007; 30(4):406-16. PubMed ID: 17457215
[TBL] [Abstract][Full Text] [Related]
11. Molecular insights into the pleiotropic effects of plasma on ex vivo-expanded T cells using DNA-microarray analysis.
Ramsborg CG; Windgassen D; Fallon JK; Paredes CJ; Papoutsakis ET
Exp Hematol; 2004 Oct; 32(10):970-90. PubMed ID: 15504553
[TBL] [Abstract][Full Text] [Related]
12. Endogenous T lymphocytes and microglial reactivity in the axotomized facial motor nucleus of mice: effect of genetic background and the RAG2 gene.
Ha GK; Huang Z; Streit WJ; Petitto JM
J Neuroimmunol; 2006 Mar; 172(1-2):1-8. PubMed ID: 16376435
[TBL] [Abstract][Full Text] [Related]
13. Mirasol PRT treatment of donor white blood cells prevents the development of xenogeneic graft-versus-host disease in Rag2-/-gamma c-/- double knockout mice.
Fast LD; DiLeone G; Cardarelli G; Li J; Goodrich R
Transfusion; 2006 Sep; 46(9):1553-60. PubMed ID: 16965583
[TBL] [Abstract][Full Text] [Related]
14. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.
Pu LY; Wang XH; Zhang F; Li XC; Yao AH; Yu Y; Lv L; Li GQ
Surgery; 2007 Jul; 142(1):67-73. PubMed ID: 17630002
[TBL] [Abstract][Full Text] [Related]
15. Skewing the T-cell repertoire by combined DNA vaccination, host conditioning, and adoptive transfer.
Jorritsma A; Bins AD; Schumacher TN; Haanen JB
Cancer Res; 2008 Apr; 68(7):2455-62. PubMed ID: 18381454
[TBL] [Abstract][Full Text] [Related]
16. Host lymphodepletion augments T cell adoptive immunotherapy through enhanced intratumoral proliferation of effector cells.
Wang LX; Shu S; Plautz GE
Cancer Res; 2005 Oct; 65(20):9547-54. PubMed ID: 16230420
[TBL] [Abstract][Full Text] [Related]
17. Human myoblast engraftment is improved in laminin-enriched microenvironment.
Silva-Barbosa SD; Butler-Browne GS; de Mello W; Riederer I; Di Santo JP; Savino W; Mouly V
Transplantation; 2008 Feb; 85(4):566-75. PubMed ID: 18347536
[TBL] [Abstract][Full Text] [Related]
18. A bioluminescence imaging based in vivo model for preclinical testing of novel cellular immunotherapy strategies to improve the graft-versus-myeloma effect.
Rozemuller H; van der Spek E; Bogers-Boer LH; Zwart MC; Verweij V; Emmelot M; Groen RW; Spaapen R; Bloem AC; Lokhorst HM; Mutis T; Martens AC
Haematologica; 2008 Jul; 93(7):1049-57. PubMed ID: 18492693
[TBL] [Abstract][Full Text] [Related]
19. The effect of artificial antigen-presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor T cells.
Zappasodi R; Di Nicola M; Carlo-Stella C; Mortarini R; Molla A; Vegetti C; Albani S; Anichini A; Gianni AM
Haematologica; 2008 Oct; 93(10):1523-34. PubMed ID: 18728033
[TBL] [Abstract][Full Text] [Related]
20. GMP production of anti-tumor cytotoxic T-cell lines for adoptive T-cell therapy in patients with solid neoplasia.
Turin I; Pedrazzoli P; Tullio C; Montini E; La Grotteria MC; Schiavo R; Perotti C; Locatelli F; Carretto E; Maccario R; Siena S; Montagna D
Cytotherapy; 2007; 9(5):499-507. PubMed ID: 17786611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
